Investment Rating - The investment rating for the company is "Buy-A" with a target price of HKD 16.59, maintaining the rating [5]. Core Insights - The company reported a revenue of CNY 11.799 billion for 2024, a year-on-year increase of 5.32%, while the net profit attributable to shareholders was CNY 1.303 billion, a decrease of 20.80% [1]. - The company is focusing on expanding its HNB (Heated Not Burned) product line as a second growth curve, with positive trial results for the new product glo Hilo [4][10]. - The company has increased its R&D investment to CNY 1.572 billion in 2024, a year-on-year growth of 41.30%, indicating a commitment to diversifying into nebulization technology and medical applications [4]. Revenue Performance - In 2024, the company's self-owned brand revenue grew by 34.00% to CNY 2.475 billion, accounting for 21.00% of total revenue [2]. - The revenue from enterprise clients was CNY 9.324 billion, a slight decrease of 0.30%, but showed a recovery trend with a 9.70% increase in H2 2024 [3]. - The company achieved revenue of CNY 6.762 billion in H2 2024, reflecting an 11.22% year-on-year increase [1]. Market Performance - The company experienced a strong recovery in the European and American markets, with revenues of CNY 4.24 billion and CNY 20.24 billion respectively, representing year-on-year growth of 14.00% and 37.20% [2]. - In H2 2024, the revenue from the U.S. and European markets was CNY 2.27 billion and CNY 10.95 billion, with growth rates of 8.83% and 11.61% respectively [2]. Profitability Analysis - The gross profit margin for 2024 was 37.39%, a decrease of 1.36 percentage points year-on-year, primarily due to changes in product mix [9]. - The adjusted net profit margin for 2024 was 11.04%, down 3.69 percentage points year-on-year, with H2 2024 adjusted net profit margin at 9.17%, a decline of 6.18 percentage points [9]. Future Projections - Revenue projections for 2025-2027 are CNY 12.823 billion, CNY 14.475 billion, and CNY 16.878 billion, with year-on-year growth rates of 8.68%, 12.88%, and 16.60% respectively [10]. - Net profit projections for the same period are CNY 1.476 billion, CNY 1.809 billion, and CNY 2.242 billion, with growth rates of 13.31%, 22.49%, and 23.94% respectively [10].
思摩尔国际（06969）：24H2营收增速转正，开拓HNB第二增长曲线